Edgar Suzanna, Zulhairy-Liong Nurul Angelyn, Ellis Melina, Trivedi Shuchi, Zhu Danqing, Odongo Jeffrey Ochieng, Goh Khean-Jin, Capelle David Paul, Shahrizaila Nortina, Kennerson Marina L, Ahmad-Annuar Azlina
Neurology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia.
Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia.
Neurogenetics. 2025 Jan 13;26(1):19. doi: 10.1007/s10048-024-00798-0.
Intermediate CAG repeats from 29 to 33 in the ATXN2 gene contributes to the risk of amyotrophic lateral sclerosis (ALS) in European and Asian populations. In this study, 148 ALS patients of multiethnic descent: Chinese (56.1%), Malay (24.3%), Indian (12.8%), others (6.8%) and 100 neurologically normal controls were screened for the ATXN2 CAG repeat expansion. The most common repeat length in both the controls and patients was 22. No familial ALS patients were positive for the intermediate repeat sizes (29-33), while four sporadic patients (2.8%) were positive, with one harbouring a rare ATXN2 homozygous 32 repeat expansion, and a likely pathogenic variant in SPAST. All four patients had limb-onset ALS. Despite representing the smallest ethnic group in our patient cohort, three of the four patients with intermediate repeat sizes were of Indian ancestry. This study, which is the first in Malaysia and Southeast Asia, shows that ATXN2 intermediate risk expansions are relevant to ALS in these populations and will help to inform future genetic testing strategies in the clinic.
ATXN2基因中29至33个CAG重复序列的中等长度重复与欧洲和亚洲人群的肌萎缩侧索硬化症(ALS)风险相关。在本研究中,对148例多民族血统的ALS患者(华裔占56.1%,马来裔占24.3%,印度裔占12.8%,其他占6.8%)和100名神经功能正常的对照者进行了ATXN2基因CAG重复序列扩增筛查。对照者和患者中最常见的重复长度均为22。家族性ALS患者中没有中等重复长度(29 - 33)阳性的,而4例散发性患者(2.8%)为阳性,其中1例携带罕见的ATXN2纯合32重复序列扩增,且伴有SPAST基因的一个可能致病变异。所有4例患者均为肢体起病型ALS。尽管印度裔在我们的患者队列中占比最小,但4例中等重复长度患者中有3例为印度裔。本研究是马来西亚和东南亚地区的首例研究,表明ATXN2中等风险扩增与这些人群的ALS相关,并将有助于为临床未来的基因检测策略提供参考。